期刊文献+

膀胱肿瘤复发风险的多因素分析(附50例报告) 被引量:1

Multivariate Analysis of Recurrent Risk on Bladder Tumor
下载PDF
导出
摘要 目的探讨膀胱肿瘤术后复发的危险因素,以提高肿瘤的治疗效果。方法选择肿瘤分期、肿瘤分级、肿瘤形态、肿瘤大小、多发性、肿瘤来源、发生部位、组织来源、尿细胞学检查、手术方式、及术后规律随访与否等十一项候选指标,用Cox逐步比例-风险模型进行回归分析,筛选能够预测膀胱肿瘤术后复发的相关性因素。结果膀胱肿瘤分期、形态、大小、来源、肿瘤的多发性及术后定期随访历史等六项指标与膀胱肿瘤术后复发直接相关。结论分析六项影响因子可以评估膀胱肿瘤的复发风险,对临床膀胱肿瘤的治疗具有重要意义。 Objective to study the recurrent factor of bladder tumor after surgery for promotion of therapeutic efficacy. Methods select tumor stage.tumor grade.tumor size.tumor configuration.tumor histology.multiplicity.recurrance history. resident area.urine cytology.surgery .follow-up history as screening target to analyze by Cox proportion-hazard model, and screen dependent factor which can be used to predict tumor recurrent risk after surgery. Result tumor stage.tumor appearance.tumor size.recurrance history.tumor multiplicity and history of regular follow-up are related to tumor recurrence after surgery. Conclusion aggregate analyze these hazard factors can evaluate recurrent risk of tumor,and it is significant to therapy of bladder tumor.
出处 《遵义医学院学报》 2008年第1期23-27,共5页 Journal of Zunyi Medical University
关键词 膀胱肿瘤 复发 多因素分析 Bladder tumor recurrence Multivariate analysis
  • 相关文献

参考文献17

  • 1Fitzaptric JM, West AB,Butler MR et al.Superficial bladder tumors.the importance of recurrence pattern following initial resection[J]. J Urol,1986,135:920-922.
  • 2Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J et al. Multivariate analysis of the prognostic factors of primary superficial bladder cancer[J].J Urol,200,163:73-78.
  • 3Dalesio O,Schulman CC,Sylvester R et al. Pronnostic factors in superficial bladder tumors. A study of the European Organization for Research on Ttreatment of Cancer : Genitourinary TractCancer Cooperative Group[J]. J Urol, 1983, 129:730-733.
  • 4Herr HW, Badalament RA ,Amato DA et al. Superficial bladder cancer treated with baciUus Calmette-guerin. A multivariate analysis of factor affecting tumor progression [J]. J Urol, 1989,141:22-29.
  • 5Parmar MKB Freedman IS, Hargreave TB et al. Prognostic factors for recurrence and follow-up policies in the treatment of superficial bladder cancer :report from the british medical research council subgroup on superficial bladder cancer[J]. J Urol, 1989,142:284-288.
  • 6Mulders PFA, van der Meyden APM ,Doesburg WH et al. Prognostic factors in pTa-pT, superficial bladder tumors treated with intravesical instillation[J]. Br J Urol, 1994, 73: 403-408.
  • 7Sato N, Sumiya H, Lsaka Set al. Prognostic factors for progression of superficial bladder cancer [J].Jap J Urol,1992, 83:1263-1269.
  • 8Chopin dk ,popov z, ravery vet al. Prognostic factors for progression in superficial bladder cancer [J].world J Urol, 1993,11:148-152.
  • 9Fitzaptric JM. superficial bladder carcinoma.factors affecting the natural history[J]. World J Urol, 1993,11:142-147.
  • 10Reading J, Hall RR, Parmar MKB. The application of a prognostic factor analysis for Ta.T1 bladder cancer in routine urological practice[J].Br J Urol, 1995,75:604-607.

同被引文献11

  • 1Sauter G, Algaba F, Amin M, et al. Tumour of urina- ry system: nonqnvasive urothelial EM3// Eble J N, Sauter G, Epstein J I, et al. WHO Classifiction of Tumour of urinary system and male genital organs. Ly- on: IARCC Press, 2004: 116-119.
  • 2Sobin L H, Gospodariwicz M K, Wittekind C. TNM classification of malignant tumors[M]. 7th ed. Ox-ford: Wiley-Blackwell, 2009: 262-265.
  • 3Piergentili R, Carradori S, Gulia C, et al. Bladder cancer: innovative approaches beyond the diagnosis[-J:. Curr Med Chem, 2014, 21(20)= 2219-2236.
  • 4Soukup V, Dugkovd J, Pegl M, et al. The prognostic value of T1 bladder cancer substaging: a single institu tion retrospective study:J:. Urol Int, 2014, 92 (2): 150-156.
  • 5Canter D J, Revenig L M, Smith Z L, et al. Re-exami- nation of the natural history of high-grade T1 bladder cancer using a large contemporary cohortEJ:. Int Braz J Urol, 2014, 40(2): 172-178.
  • 6Liss M, Osann K, Ornstein D. Positive surgical mar gins during robotic radical prostatectomy: a contempo- rary analysis of risk factors[J]. BJU Int, 2008, 102 (5): 603-608.
  • 7Oderda M, Ricceri F, Pisano F, et al. Prognostic fac tors including Ki-67 and p53 in Bacillus Calmette-Guer- in-treated non-muscle-invasive bladder cancer: a pro- spective study[J]. UrolInt, 2013, 90(2): 184-190.
  • 8Lightfoot A J, Breyer B N, Rosevear H M, et al. Multi-institutional analysis o{ sequential intravesical gemcitabine and mitomyein C chemotherapy for non- muscle invasive bladder cancer[J:. Urol Oncol, 2014, 32(1) : 35.
  • 9张惠敏,李鸣,靳风烁,叶锦.膀胱肿瘤复发机制的研究进展[J].现代生物医学进展,2009,9(11):2197-2200. 被引量:6
  • 10伍季,吕萍,李云祥.膀胱上皮癌ΔNp63、p53及ki-67基因表达与预后的相关性研究[J].现代泌尿外科杂志,2011,16(2):152-155. 被引量:4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部